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Complexes of lanthanum(III) with bis-coumarins: 3,3 -benzylidene-bis(4-hydroxy-2H-1-benzopyran-2-one) (H2L1) and bis(4-
hydroxy-2-oxo-2H-chromen-3-yl)-(1H-pyrazol-3-yl)-methane (H2L2) were synthesized by reaction of lanthanum(III) salt and
the ligands, in amounts equal to metal : ligand molar ratio of 1 : 2. The complexes were prepared by adding an aqueous solution
of lanthanum(III) salt to an aqueous solution of the ligand subsequently raising the pH of the mixture gradually to circa 5.0 by
adding dilute solution of sodium hydroxide. The lanthanum(III) complexes with bis-coumarins were characterized by diﬀerent
physicochemical methods—elemental analysis, IR-, 1H-, and 13C-NMR-spectroscopies, and mass spectral data. The spectral data
of lanthanum(III) complexes were interpreted on the basis of comparison with the spectra of the free ligands. This analysis showed
that in the La(III) complexes, the ligands coordinated to the metal ion through both deprotonated hydroxyl groups. On the basis
of the ν(C=O) red shift observed, participation of the carbonyl groups in the coordination with the metal ion was also suggested.
In the present study, we performed a cytotoxic-eﬀects screening of the lanthanum complexes with H2L1 and H2L2 in a panel of
human tumor cell lines, using the standard MTT-dye reduction assay for cell viability. The panel consisted of the acute myeloid
leukemia-derived HL-60 and the chronic myeloid leukemia-derived BV-173. Following a 24-hour treatment of BV-173 cells with
lanthanum complex of H2L1 at 100 or 200μM led to a DNA-laddering. The ﬁndings suggest that the observed cytotoxicity of the
lanthanum complex of H2L1 on BV-173 is at least partly mediated through induction of programmed cell death.
Copyright © 2006 Irena Kostova et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
The coumarins constitute an important class of compounds,
with several types of pharmacological agents possessing an-
ticancer, anti-HIV, anticoagulant, and spasmolytic and an-
tibacterial activity among others. Of the many actions of
coumarins, antioxidant and antiproliferative eﬀects stand
out. A large number of structurally novel coumarin deriva-
tives has ultimately been reported to show substantial cyto-
toxic activity in vitro and in vivo.
Subsequent analysis of scientiﬁc literature revealed nu-
merous reports on the antiproliferative and antitumor activ-
ities of a variety of coumarin compounds, for example, both
coumarin itself and 7-hydroxycoumarin have been reported
to inhibit the proliferation of a number of human malig-
nant cell lines in vitro [1–4] and have demonstrated activ-
ity against several types of animal tumors [5–9]. These com-
pounds have also been reported in clinical trials to demon-
strate activity against prostate cancer, malignant melanoma,
and metastatic renal cell carcinoma [10–12].
For coumarins, generally the in vitro structure-activity
relationship studies have shown that cytotoxicity is found
with derivatives containing ortho-dihydroxy substituents.
Also, the chemical-structure/biological activity study of the
coumarins showed that the addition of a cathecolic group to
the basic structure induces increased cytotoxic activity in tu-
mor cell lines [13]. The diﬀerent cytotoxic values found for
the coumarins could be related to the presence and the posi-
tions of the hydroxyls in their structures.
The complexes of rare earth ions have aroused much
interest. Lanthanides are a subject of increasing interest in
bioinorganic and coordination chemistry [14, 15].
Nowadays, a lot of studies report complexes of coumarin
derivatives with rare earth metals, which possess bio-
logical activity. Thus, lanthanide complexes of 3-sulfo-4-
hydroxycoumarin [16] and bis(4-hydroxy-3-coumarinyl)-
aceticacid[17]havebeensynthesizedandcharacterized.The
complexes have revealed good anticoagulant action.
Lanthanides manifest an antitumor activity. Further-
more,literaturedatashowthatthecoumarinshavealsothese2 Bioinorganic Chemistry and Applications
properties. These previous data from literature are in ac-
cordance with our investigations. They give us a reason to
suppose that complexes of coumarins with lanthanum could
present interesting metalorganic compounds with antitumor
activity. As a result from our earlier work, the cytotoxic pro-
ﬁle of some complexes of mendiaxon, warfarin, coumachlor,
and niﬀcoumar with lanthanides against P3HR1, K-562, and
THP-1 cell lines was proved [18–23]. With the relatively re-
sistant CML-derived erythroleukemic K-562 cell line, we ob-
tained very interesting in vitro results. It is noteworthy that
the lanthanide complexes with niﬀcoumar have pronounced
cytotoxic eﬀects. They have strong cell proliferation inhibit-
ing eﬀects (only about 30% of the cells were survival). This
means that the resistant tumor cells may be inhibited signif-
icantly with lanthanide complexes. This means also that the
spectrum of cytotoxicity of these complexes is diﬀerent from
cis-DDP(II) and from Pt(II) complexes. These results are of
some interest as a possibility to inﬂuence resistant tumors.
The corresponding lanthanide salts are found to be of very
lowormissingactivity.Sofar,wecanconcludethatthestruc-
ture metal-ligand determines the antitumor spectrum of the
new complexes. Those in vitro eﬀects are not so clearly ex-
pressed as it is in the case of cis-DDP(II). Nevertheless their
studying is interesting in connection with other cell lines and
tumors in order to ﬁnd out the diﬀerences in their spectrum
of activity.
Little is known about the complexing ability of lan-
thanum(III) with coumarins. A survey of the literature re-
veals that no work has been done on the reactions of lan-
thanum(III) with H2L1 and its derivatives. It was, therefore,
considered worthwhile to study the complexation, and in
the ﬁrst place, the objective of this study was to determine
whether the new complexes were active as cytotoxic agents.
In the present study, we perform investigation of the co-
ordination ability of H2L1 and H2L2 in complexation reac-
tion with lanthanum(III). The obtained La(III) complexes
with these coumarin ligands were characterized by elemen-
tal analysis, physicochemical methods, and mass-, NMR-,
and IR-spectroscopy. The complicated vibrational spectra of
lanthanum(III) complexes were interpreted on the basis of
comparison with the vibrational spectra of the free ligands.
Themostsensitivetocoordinationmodesoftheligandshave
been assigned and discussed.
We observed that La(III) possesses a cytotoxic activity,
and literature data show that the coumarins have also these
properties. That is why our synthesis of complexes of La(III)
is taken into consideration with cytotoxic screening and fur-
ther pharmacological study.
EXPERIMENTAL
Chemistry
ThecompoundsusedforpreparingthesolutionswereMerck
products,p.a.grade:La(NO3)3 ·6H2O.H2L1andH2L2were
used for the preparation of metal complexes as ligands
(Scheme 1). The synthesis of the ligands was described re-
cently by us [24].
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(a) H2L1 = 3,3 -benzylidene-bis(4-hydroxy-2H-
1-benzopyran-2-one).
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(b) H2L2 = bis(4-hydroxy-2-oxo-2H-chromen-
3-yl)-(1H-pyrazol-3-yl)-methane.
Scheme 1: Structures of the ligands.
The complexes of lanthanum(III) with H2L1 and H2L2
were synthesized by reaction of lanthanum(III) salt and
the ligand, in amounts equal to metal : ligand molar ra-
tio of 1 : 2. The ligands were insoluble in water. On rais-
ing the pH by the dropwise addition of a dilute solution
of sodium hydroxide (0.1molL−1), the ligands were dis-
solved. The complexes were prepared by adding aqueous so-
lution of Ln(III) salts (1mmol) to the solution of the re-
spective ligand (2mmol). The reaction mixtures were stirred
with an electromagnetic stirrer at 25◦C for one hour. At the
moment of mixing of the solutions, precipitates were ob-
tained. The precipitates were ﬁltered, washed several times
with water, and dried in a desicator to constant weight.
Yields are: La(L1)(OH) ·H2O (94%); La(L2)(OH) · 2H2O
(89%).
The complexes were insoluble in water, slightly soluble in
methanol and ethanol, and well soluble in DMSO.
Thecarbon,hydrogen,andnitrogencontentsofthecom-
pounds were determined by elemental analysis.
The water content was determined by Metrohn Herizall
E55 Karl Fisher Titrator.
IR spectra (Nujol) were recorded on spectrophotometers
FTIR-8101M Shimadzu (3800–400cm−1) and Perkin-Elmer
GX auto image system (700–200cm−1).Irena Kostova et al 3
1H-NMR spectra were recorded at room temperature
on Brucker WP 250 (250MHz) spectrometer in DMSO-d6.
Chemical shifts are given in ppm.
13C-NMR spectra were recorded at ambient temperature
on Brucker 250WM (62.9MHz) spectrometer in DMSO-d6.
Chemical shifts are given in ppm, downﬁeld from TMS.
Mass spectra were recorded on a Jeol JMS D 300 double
focusing mass spectrometer coupled to a JMA 2000 data sys-
tem. The compounds were introduced by direct inlet probe,
heated from 50◦C to 400◦C at a rate of 100◦C/min. The ion-
ization current was 300mA, the accelerating voltage 3kV,
and the chamber temperature 150◦C.
Pharmacology
Inthepresentstudy,weperformedacytotoxic-eﬀectsscreen-
ing of the lanthanum complexes with H2L1 and H2L2 in a
panel of human tumor cell lines, using the standard MTT-
dye reduction assay for cell viability. The panel consisted of
the acute myeloid leukemia-derived HL-60 and the chronic
myeloid leukemia-derived BV-173.
In order to shed some light over the mechanistic partic-
ulars engaged in the cytotoxic mode of action of the new
lanthanum complexes, we carried out DNA-isolation and
gel electrophoresis to evaluate the ability of the more active
lanthanum complex with H2L1 to trigger programmed cell
death.
Cellculturemaintenance,drugsolutions,andtreatment
The human tumor cell lines used in the present study were
supplied from the Department of Human and Animal Cell
Cultures at the German Collection of Microorganisms and
Cell Cultures. They were maintained as suspension—type
cultures at standard conditions: humidiﬁed atmosphere with
5% carbon dioxide, at 37◦C in a “Heraeus” incubator, us-
ing RPMI-1640 medium, supplemented with 10% heat-
inactivated fetal calf serum and 2mM L-glutamine. Cells
were kept in log phase via replacement of cellular suspension
aliquots by fresh medium two or three times weekly.
Stock solutions of the new investigated lanthanum com-
plexes(200mM)werefreshlypreparedinDMSOanddiluted
with RPMI-1640 in order to obtain the desired ﬁnal concen-
trations. Less than 1% of the solvent was available at the ﬁnal
dilutions obtained.
All of the procedures concerning the cell culture mainte-
nance, drug dissolution, and treatment were carried out in a
“Heraeus” Laminar ﬂow cabinet.
Cellviabilitydetermination(MTTassay)
The MTT-dye reduction assay was carried out as described
by Mosmann [25] with some modiﬁcations [26]. Brieﬂy,
exponentially growing cells were seeded in 96-well plates
(100μL aliquots/well) at a density of 1 × 105 cells/mL. Af-
ter a 24hours incubation at 37◦C, they were exposed to
either the lanthanum complex of H2L1 or the lanthanum
complex with H2L2 (12.5–200μM) for 72hours. After the
incubation period expired, 10μL aliquots of MTT solu-
tion (10mg/mL in PBS) were added to every well. There-
after the plates were incubated for 4hours at 37◦C and the
formazancrystalsformedweredissolvedthroughadditionof
100μL/well 5% formic acid in 2-propanol (Merck). The ab-
sorption of the samples was measured using an ELISA reader
(Uniscan Titertec) at wavelength of 580nm. The blank con-
sisted of 100μL RPMI 1640 medium (Sigma), 10μLM T T
stock, and 100μL 5% formic acid in 2-propanol.
DNAisolationandgelelectrophoresis
The DNA extraction and horizontal gel electrophoresis pro-
c e d u r e sw e r ee x e c u t e da sp r e v i o u s l yd e s c r i b e d[ 26]. About
5 × 106 t r e a t e da n du n t r e a t e dB V - 1 7 3c e l l sw e r ew a s h e di n
PBS. Cell pellets were re-dispersed in 0.25mL PBS and lysed
through addition of 0.5mL buﬀer containing 0.5% Triton
X-100, 20mM Tris-HCL, and 1mM EDTA (pH = 7.4).
Samples were incubated on ice for 5minutes and then cen-
trifugedat13000rpmfor20minutes.Thesupernatantswere
transferred into 2mL Eppendorf safe lock tubes and then
0.937mL 2-propanol as well as 0.187mL 6M solution of
NaCl were added to each sample. The tubes were gently
agitated and incubated at −20◦C overnight in order to al-
low DNA precipitation. The samples were centrifuged for
20minutes at 13000rpm, the supernatants were decanted
and DNA was washed in 1mL ice cold 70% ethanol and then
air dried. The isolated DNA was dissolved in 20μLp u r i ﬁ e d
waterandanalyzedbygelelectrophoresisin0.8%agarosegel.
Finally DNA was visualized by means of ethidium bromide
staining and UV transillumination and photographed with a
ﬁxed digital camera (Bio Doc ITTM system).
Statistics
ThedataprocessingincludedtheStudentt testwith p ≤ 0.05
taken as signiﬁcance level, using Microsoft EXCEL for PC.
RESULTS AND DISCUSSION
Chemistry
The complexes were characterized by elemental analysis. The
metal ion was determined after mineralization. The water
contentinthecomplexeswasdeterminedbyKarlFisheranal-
ysis. The formation of the complexes was conﬁrmed by IR-
spectroscopy, 1H, 13C-NMR-spectrometry,andmassspectral
data.
Table 1 shows the data of the elemental analysis of the
complexes serving as a basis for the determination of their
empiricalformulae.TheelementalanalysisdataoftheLa(III)
complexes obtained are in agreement with the presented for-
mulas.
The suggested formulas were further conﬁrmed by
mass spectral fragmentation analysis. As it is seen from
Table 2, the ﬁrst peaks in the La(III) complexes spec-
tra (although with low intensity) correspond to the mass
weight of the complex formation (La(L1)(OH) ·H2Oa n d4 Bioinorganic Chemistry and Applications
Table 1: Elemental analysis data for La(III) complexes with bis-
coumarins.
Found/calculated
Complex %C %H %N %H2O% L a
La(L1)(OH) ·H2O 51.81 3.32 — 2.85 24.23
51.37 2.91 — 3.08 23.80
La(L2)(OH) ·2H2O 44.94 3.05 5.07 6.35 23.22
44.59 2.87 4.73 6.08 23.48
L1 = C25H14O6
2−
L2 = C22H12N2O6
2−.
La(L2)(OH) ·2H2O, resp) and the next ones to that of the
ligands. The results thus obtained are in agreement with
metal : ligand ratio 1 : 1 in the investigated complexes. The
data of mass spectral fragmentation of the ligands and of the
complexes are presented in Table 2.
IRspectraofthecomplexes
The mode of bonding of the ligands to La(III) was elucidated
by recording the IR spectra of the complexes as compared
with that of the free ligands.
IRspectraofthecompoundswererecordedonsolidstate
in Nujol in the range 3800–400cm−1. The data of the IR
spectraofH2L1,H2L2,andofthelanthanumcomplexeswith
these ligands are presented in Table 3.
IRSpectrumofthelanthanumcomplexofH2L1
The bands appear in the IR spectrum of H2L1 at 3074, 3032;
1660, 1617; 1605, 1568; 1496, 1182, 1160, 1092, 1074cm−1.
The bands at 1660 and 1617cm−1 can be attributed to the
stretching vibrations of the carbonyl groups of the lacton
rings. Bands at 1605 and 1568cm−1 can be related to the
stretching vibrations of the conjugated oleﬁnic system. The
vibrations at 1496cm−1 correspond to the aromatic systems.
A broad band, characteristic of νOH of coordinated water,
was observed in the range 3300–3400cm−1 in the spectrum
of the complex. The weak bands observed at 3074 and 3032
cm−1 in the spectrum of the free ligand are missing in the
spectrumof the complex. A comparison of theinfrared spec-
tra of the ligand and of the complex reveals the disappear-
ance of absorption bands observed in the free ligand at 3074,
3032cm−1 and 1345, 1336cm−1 associated with the stretch-
ing and deformation OH of the phenolic groups, indicating
the loss of phenolic protons on complexation, thus forming
metal-oxygen bonds, which appear as bands in the far IR re-
gion.
The νC=O bands at 1660 and 1617cm−1 exhibit a shift of
30–40cm−1 to lower wavenumber values on complexation,
which may be taken as evidence for the participation of the
C=O groups in coordination.
The C−Ca n dC −O stretch and the C−O−C band are all
shifted in the complex. Similar frequency shifts are observed
for the other complexes and are attributed to complexation
of the positive ion with the carbonyl oxygen [27].
Table 2:Massspectraldataofbis-coumarinsandtheirLa(III)com-
plexes.
Ligand M/z (%) Complex M/z (%)
H2L1=C25H16O6
412 8
La(L1)(OH) ·H2O
586 8
249 100 410 35
221 17 305 100
162 20 176 100
120 37 — —
H2L2=C22H14N2O6
402 0
La(L2)(OH) ·2H2O
596 1
241 16 490 5
240 100 460 3
162 72 410 1
120 74 307 65
92 98 176 100
IRSpectrumofthelanthanumcomplexofH2L2
The bands appear in the IR spectrum of H2L2 at 3139, 3070;
1669, 1635; 1610, 1539; 1496, 1187, 1150, 1110, 1044cm−1.
The bands at 1669 and 1635cm−1 can be attributed to the
stretching vibrations of the carbonyl groups of the lacton
rings. Bands at 1610 and 1539cm−1 can be related to the
stretching vibrations of the conjugated oleﬁnic system. The
vibrations at 1496cm−1 correspond to the aromatic systems.
Bands at 1620–1417cm−1 can be attributed to the stretching
vibrations of pyrazol and they remain almost the same in the
complex.
A broad band, characteristic of νOH of coordinated wa-
ter, was observed in the range 3300–3400cm−1 in the spec-
trum of the complex. The weak bands observed at 3139 and
3070cm−1 in the spectrum of the free ligand are missing in
the spectrum of the complex. A comparison of the infrared
spectra of the ligand and of the complex reveals the disap-
pearance of absorption bands observed in the free ligand at
3139, 3070cm−1 and 1360, 1300cm−1 associated with the
stretching and deformation OH of the phenolic groups, in-
dicating the loss of phenolic protons on complexation, thus
forming a metal-oxygen bonds, which appear as bands in the
far IR region.
The νC=O bands at 1669 and 1635cm−1 exhibit a shift of
20–30cm−1 to lower wavenumber values on complexation,
which may be taken as evidence for the participation of the
C=O groups in coordination.
The C−Ca n dC −O stretch and the C−O−Cb a n da r ea l l
shifted in the complex. Similar frequency shifts are observed
for the other complexes and are attributed to complexation
of the positive ion with the carbonyl oxygen [27].
IRspectraofthecompoundswererecordedonsolidstate
in Nujol in the range 700–220cm−1. The spectra of the com-
plexes showed new bands, in comparison with these of the
free ligands, which have been assigned to the rocking, wag-
gling, and metal-oxygen stretching vibrations.Irena Kostova et al 5
Table 3: Selected experimental IR frequencies of the ligands and their La(III) complexes (cm−1).
Compound νOH/H2O ν(C=O) ν(C=C) ν(Py) ν(Ar) δ(COH) ν(C−O)
— — — — — — 1182m —
H2L1=C25H16O6
3074m 1660s 1605s — 1496m 1345m 1160m 772
3032m 1617s 1568s — — 1336m 1092s 750
— — — — — — 1074m —
— — — — — — 1192w —
La(L1)(OH) ·H2O
3391br 1620sh 1508s — 1446m — 1150w 757
— 1600s — — — — 1109m —
— — — — — — 1109m —
— — — — — — 1094w —
— — — 1620 — — 1187m —
H2L2=C22H14N2O6
3139m 1669s 1610s 1559 1496m 1360m 1150m 770
3070m 1635s 1539s 1507 — 1300m 1110s 748
— — — 1417 — — 1044m —
— — — 1622 — — 1194w —
La(L2)(OH) ·2H2O
3379br 1653sh 1520s 1560 1460m — 1145w 759
— 1599s — 1508 — — 1109m —
— — — 1418 — — 1054w —
a br-broad, s-strong, m-medium, sh-shoulder, w-weak.
1H-and13C-NMRspectraoftheligandsand
theirLa(III)complexes
Metal ion coordination with ligand by means of oxygen
atoms of C=O groups and of the deprotonated hydroxyl
groups was shown owing to data of 1Ha n d13C-NMR spec-
tra.
Proton spectra of the compounds recorded at 250MHz
in DMSO-d6 conﬁrmed the formation of the complex. The
typical chemical shifts of the 1H-NMR spectra in DMSO-
d6 are presented in Table 4.A si ti ss e e nf r o mTable 4, dif-
ferent chemical shifts were observed in the complexes and
these changes were attributed to coordination of the ligands
to La(III).
13C-NMR spectra of the ligands and of the complexes
were recorded at 62.9MHz in DMSO-d6. The results of 13C-
NMR spectra of the compounds in δd (ppm) are presented
in Table 5.
The ligand H2L1 showed seven signals in the 13C-
NMR spectra resonating at δ 131.91, 128.08, 126.70, 125.58,
123.92,123.76,and115.95ppmforthirteenmethinecarbons
(Table 5). In agreement with literature data, the peaks at δ
131.91, 123.92, 123.76, and 115.95ppm were related to C-7,
C-5,C-6,andC-8(theatomnumberingisinagreementwith
the scheme in Table 4) carbons, respectively, of the coumarin
moieties. The signals at δ 128.08, 126.70, and 125.58ppm
were assigned to C-3  (and C-5 ), C-4 , and C-2  (and C-6 )
carbons of the phenyl ring. The chemical shifts at δ 165.36,
164.87, 152.23, 139.94, 117.96, and 104.13ppm are due to
the C-2, C-4, C-8a, C-1 , C-4a, and C-3 quaternary carbons,
respectively. Due to electron transfer from the hydroxyl and
carbonyl oxygen atoms to La(III), a diﬀerence in chemical
shifts was observed for the neighboring C-4, C-3, and C-2
carbon atoms of the complex and they conﬁrmed the ex-
pected coordination of the ligand through both deproto-
nated hydroxyl and carbonyl oxygen atoms. The other car-
bon atoms were only slightly aﬀected from the coordination
of the metal. Similar chemical shifts were observed for the
other ligand and its complex (Table 5). On the basis of the
results thus obtained, it was suggested that the ligands act as
tetradentate ones in the La(III) complex formation.
I no u rp r e v i o u si n v e s t i g a t i o n ,w eh a v ep e r f o r m e da c c u -
ratedensityfunctionaltheorystudy(DFT)oftheneutraland
deprotonated ligands [28]. The results obtained showed that
the most probable reactive sites for electroﬁlic attack (metal
binding) in the L2− are the carbonylic and the deprotonated
hydroxylic oxygen atoms. Our IR and NMR spectral data
conﬁrmed that the carbonylic and deprotonated hydroxylic
oxygen atoms are included in the coordination to the metal
ion in the complexes studied, as described in the previous
sections. Further, molecular modeling was performed to ob-
tain the most probable molecular geometry of the complex.
Our calculations have showed that it is unfavorable for one
metal ion to coordinate to all four oxygen atoms of one lig-
and. Thus, on the basis of the experimental and theoretical
results, we were able to suggest that in the metal complex,
the metal ion coordinates to the carbonylic (O9) and depro-
tonated hydroxylic oxygen atoms (O28) from one ligand and
through the carbonylic (O27) and deprotonated hydroxylic
oxygen atoms (O10) from a second ligand, as it is shown6 Bioinorganic Chemistry and Applications
Table 4: 1H-NMR spectral shifts, δ (ppm) of the ligands and their
La(III) complexes (250MHz, DMSO-d6).
Compound δ (ppm)
H5−H8
a H9
a H2 −H6 a
H2L1=C25H16O6 7.11–7.39 6.37 7.56–7.92
La(L1)(OH) ·H2O 6.98–7.26 6.27 7.37–7.83
H2L2=C22H14N2O6 7.23–7.55 6.36 7.83–8.15
La(L2)(OH) ·2H2O 7.03–7.51 5.79 7.81–8.00
7
8
O 2 O O 2 O 8a
8
7
6
54
393 4a
6
5
OH
CH
OH
6 
5 
1 
2 
3 
4 
in Scheme 2. The other carbonylic (O27) and deprotonated
hydroxylic oxygen atoms (O10) from the ﬁrst ligand will co-
ordinate with another metal ion, as well, the carbonylic (O9)
and deprotonated hydroxylic oxygen atoms (O28) from the
second ligand will coordinate to the next metal ion, form-
ing a polymeric structure. The other two coordination sites
of the metal ion (Scheme 2) are occupied from an OH group
and a water molecule. Thus, the metal ion is 6 coordinate,
the ligand is tetradentate, and the metal : ligand ratio is 1 : 1,
as the experimental results showed.
Pharmacology
Invitrocytotoxicity
The spectrophotometric data regarding the MTT-dye reduc-
tion assay are summarized in Table 6.
The newly-synthesized lanthanum complexes exhibited
cytotoxic eﬀects against HL-60 and BV-173 human leukemic
cell,thatenabledtheconstructionofconcentration-response
curves, as presented in Figures 1–4. In order to allow com-
parison of their relative potencies, the IC50 values were ex-
trapolated from the concentration-response curves; these are
summarized on Table 7.
As evident from the concentration-response curve on
Figure 1, the lanthanum complex of H2L1 failed to induce
any signiﬁcant eﬀects at concentrations less than 25μMa n d
even certain stimulation of malignant cell growth was en-
countered at the lowest concentration. At a concentration
of 50μM, however, the investigated compound reduced the
viable cells by circa 25%, whereas at 100μM, the vital cells
were less than 20%. At the highest concentration exploited
in our experimental system (200μM), an almost total eradi-
cation of the malignant cells was encountered with less than
Table 5: 13C-NMR spectral shifts, δ (ppm) of the ligands and their
La(III) complexes (62.9MHz, DMSO-d6).
Atom δ (ppm)
H2L1 La(L1)(OH) ·H2OH 2L2 La(L2)(OH) ·2H2O
C-2 165.3 164.6 167.9 170.0
C-4 164.9 152.7 163.9 154.8
C-8a 152.2 152.5 152.7 154.6
C-1  139.9 142.4 150.5 152.6
C-7 131.9 130.9 134.3 131.1
C−3  128.1 127.7 131.6 130.0
C-5  128.1 127.7 — —
C-4  126.7 126.6 — —
C-6  125.6 124.8 — —
C-2  125.6 124.8 126.1 128.0
C-5 123.9 124.1 124.3 122.0
C-6 123.8 122.9 123.3 121.5
C-4a 117.9 119.9 119.5 120.2
C-8 115.9 115.4 115.8 115.1
C-3 104.1 103.4 101.4 103.0
C-9 35.9 37.5 30.1 33.1
O28
O9
O27 Oh
O9 La O10
O28
Ow
O10 O27
Scheme 2: Suggested metal-ligand coordination in the investigated
La(III) complexes.
4% survival fraction. The other complex exerted marginal
cytotoxic eﬀe c to nH L - 6 0w i t hc e r t a i ns t i m u l a t i o no fc e l l u -
lar proliferation at concentrations up to 100μM and small
reductionofthecellviabilitybycirca13%atthehighestcon-
centration of 200μM.
The data obtained from the evaluation of the cytotoxic
activity of the lanthanum complex of H2L1 on BV-173 cells
is shown in Figure 3. As evident from the concentration-
response curve, it caused a small increase of cell viability at
the lowest concentrations of 12.5 and 25μM by circa 8 and
10%, respectively. At the higher concentrations of 50μM, the
cell survival fraction was reduced by circa 58%, whereas atIrena Kostova et al 7
Table 6: Spectrophotometric data from MTT assay, concerning the cytotoxic eﬀects of the newly synthesized lanthanum complexes with
3,3 -benzylidene-bis(4-hydroxy-2H-1-benzopyran-2-one) (La-1) and bis(4-hydroxy-2-oxo-2H-chromen-3-yl)-(1H-pyrazol-3-yl)-methane
(La-2).
Cell line complex MTT-formazan absorption at 580nm
Untreated control 12.5μM2 5 μM5 0 μM 100μM 200μM
HL-60
La-1 1.22± 1.203± 0.707± 0.705± 0.446± 0.114±
0.089 0.058 0.100 0.092 0.090 0.031
La-2 0.737± 1.017± 1.028± 1.008± 0.935± 0.643±
0.052 0.007 0.007 0.051 0.071 0.058
BV-173
La-1 0.957± 1.036± 1.053± 0.403± 0.024± 0.027±
0.023 0.029 0.059 0.066 0.008 0.009
La-2 1.137± 1.464± 1.127± 1.061± 0.909± 0.859±
0.096 0.059 0.063 0.042 0.058 0.095
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Figure 1: Cytotoxic eﬀects of La-1 on HL-60 cells as assessed by the
MTT-dyereductionassayfollowinga72-hourtreatment.Eachdata
point represents the arithmetic mean ± standard deviation (error
bars) of at least 6 independent experiments.
concentrations higher than 100μM, the vital cells were less
than 3%. The lanthanum complex with H2L2 also caused
concentration-dependentcytotoxiceﬀectonBV-173cells,al-
though less pronounced than that of the lanthanum complex
of H2L1 in respect to both relative potency and maximal ef-
ﬁcacy encountered. At concentrations of 25 and 50μM, the
lanthanum complex with H2L2 reduced the viable cells by
circa 20%, whereas at the higher concentration of 100μM, it
caused circa 31% inhibition of malignant cell proliferation.
The treatment of BV-173 cells with 200μM of the lanthanum
complex with H2L2 resulted in circa 80% reduction of cell
viability.
Incontrasttotheobservedeﬀectsofthelanthanumcom-
plexes, the corresponding lanthanum(III) nitrate was prac-
tically devoid of cytotoxic eﬀects at the same experimental
conditions [18–24].
DNA-fragmentationanalysis
F o l l o w i n ga2 4 h o u r st r e a t m e n to fB V - 1 7 3c e l l sw i t hl a n -
thanum complex of H2L1 at 100 or 200μMl e dt oa nD N A -
laddering, that is indicative for the programmed cell death
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Figure 2: Cytotoxic eﬀects of La-2 on HL-60 cells as assessed by the
MTT-dyereductionassayfollowinga72-hourtreatment.Eachdata
point represents the arithmetic mean ± standard deviation (error
bars) of at least 6 independent experiments.
(Figure 5). These ﬁndings suggest that the observed cyto-
toxicity of the lanthanum complex of H2L1 on BV-173 is at
least partly mediated through induction of programmed cell
death.
CONCLUSIONS
The coordination ability of the ligands has been proved
in complexation reaction with lanthanum(III) ion. The
elemental analysis and mass spectral data conﬁrmed the
compositions of the compounds. 1H-, 13C-NMR-, and IR-
spectral analysis of the ligands and their La(III) complexes
conﬁrmed the suggested coordination of the ligands through
both the hydroxyl and carbonyl oxygen atoms.
In our hands, the two novel lanthanum complexes un-
derinvestigationexhibitedinvitrocytotoxiceﬀectsinmicro-
molar concentrations. The lanthanum complex with H2L1,
however, demonstrated far more pronounced cytotoxic ef-
fects as compared to the lanthanum complex with H2L2.
On the basis of the observed considerable cytotoxic activ-
ity of lanthanum complex with H2L1 on HL-60 and BV-173
human leukemic cells, together with its documented ability8 Bioinorganic Chemistry and Applications
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Figure 3:CytotoxiceﬀectsofLa-1onBV-173cellsasassessedbythe
MTT-dyereductionassayfollowinga72-hourtreatment.Eachdata
point represents the arithmetic mean ± standard deviation (error
bars) of at least 6 independent experiments.
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Figure 4:CytotoxiceﬀectsofLa-2onBV-173cellsasassessedbythe
MTT-dyereductionassayfollowinga72-hourtreatment.Eachdata
point represents the arithmetic mean ± standard deviation (error
bars) of at least 6 independent experiments.
Table 7: IC50 values of the lanthanum complexes with 3,3 -
benzylidene-bis(4-hydroxy-2H-1-benzopyran-2-one) (La-1) and
bis(4-hydroxy-2-oxo-2H-chromen-3-yl)-(1H-pyrazol-3-yl)-meth-
ane(La-2),derivedfromthecorrespondingconcentration-response
curves.
Cell line IC50 value (μM)
La-1 La-2
HL-60 71.92 > 200
BV-173 46.89 138.03
to trigger programmed cell death, it could be concluded
thatlanthanum complex withH2L1 deserves furtherdetailed
pharmacological and toxicological evaluation.
According to our expectations, the complexes of lan-
thanum(III) possess a cytotoxic activity and their in vitro ef-
fectsareclearlyexpressed.Theseresultsconﬁrmedourprevi-
ous observations on the cytotoxicity of lanthanum(III) com-
plexes.
123
Figure 5: Agarose gel electrophoresis of DNA, isolated from the cy-
tosolic fraction of BV-173 cells as follows: untreated control (lane
1), following a 24-hour treatment with La-1 at 200μM( l a n e2 )o r
100μM (lane 3).
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